Pulpitis
Conditions
Interventions
In a double-blind, placebo-controlled clinical trial, sixty volunteers with mild to severe preoperative pain will be divided into three groups (n=20 per group): (1) dexamentasone 4 mg/mL + ibuprofen 6
Sponsors
Universidade Federal de Campina Grande
Universidade Federal de Campina Grande
Eligibility
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Systemically healthy patients; of any gender aged; between 18 and 65 years; teeth diagnosed with symptomatic or asymptomatic irreversible pulpitis; symptomatic apical periodontitis (presence of preoperative pain); and preoperative pain ranging from level to severe on the Heft-Parker visual analogue scale
Exclusion criteria
Exclusion criteria: pregnant or breastfeeding women; patients with allergies, sensitivity or adverse reactions to Dexamethasone or Ibuprofen; individuals who received any analgesic or anti-inflammatory in the last 12 hours before treatment; and non-restorable teeth, with periodontal disease, root resorption, open apex and calcified root canals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to reduce postoperative endodontic pain within 7 days with the combined use of prednisolone and dexamethasone | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to see an increase in the anesthetic success rate and improvement in postoperative quality of life within 7 days with the combined use of ibuprofen and dexamethasone | — |
Countries
Brazil
Contacts
Public ContactFelipe Matos
Universidade Federal de Campina Grande
Outcome results
None listed